DOCUSATE\SENNOSIDES A AND B: 156 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
156
Total FAERS Reports
6 (3.8%)
Deaths Reported
59
Hospitalizations
156
As Primary/Secondary Suspect
5
Life-Threatening
Active Ingredient: DOCUSATE SODIUM\SENNOSIDES A AND B ·
First Report: 20090101 · Latest Report: 20231027
What Are the Most Common DOCUSATE\SENNOSIDES A AND B Side Effects?
#1 Most Reported
Somnolence
52 reports (33.3%)
#2 Most Reported
Gastrooesophageal reflux disease
37 reports (23.7%)
#3 Most Reported
Pneumonia aspiration
35 reports (22.4%)
All DOCUSATE\SENNOSIDES A AND B Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Somnolence | 52 | 33.3% | 0 | 41 |
| Gastrooesophageal reflux disease | 37 | 23.7% | 0 | 35 |
| Coma | 35 | 22.4% | 0 | 35 |
| Pneumonia aspiration | 35 | 22.4% | 0 | 35 |
| Fatigue | 25 | 16.0% | 0 | 5 |
| Constipation | 23 | 14.7% | 0 | 11 |
| Off label use | 21 | 13.5% | 0 | 13 |
| Cardiomyopathy | 20 | 12.8% | 0 | 5 |
| Fall | 18 | 11.5% | 0 | 9 |
| Pyrexia | 18 | 11.5% | 0 | 2 |
| Drug ineffective | 17 | 10.9% | 0 | 7 |
| Neuroleptic malignant syndrome | 17 | 10.9% | 0 | 3 |
| Troponin increased | 17 | 10.9% | 0 | 6 |
| Acute kidney injury | 16 | 10.3% | 1 | 4 |
| Rhabdomyolysis | 16 | 10.3% | 0 | 4 |
| Toxicity to various agents | 16 | 10.3% | 0 | 7 |
| Infective exacerbation of chronic obstructive airways disease | 15 | 9.6% | 0 | 0 |
| Iron deficiency | 15 | 9.6% | 0 | 3 |
| Mental disorder | 15 | 9.6% | 0 | 5 |
| Metabolic acidosis | 15 | 9.6% | 0 | 3 |
Who Reports DOCUSATE\SENNOSIDES A AND B Side Effects? Age & Gender Data
Gender: 55.9% female, 44.1% male. Average age: 61.2 years. Most reports from: AU. View detailed demographics →
Is DOCUSATE\SENNOSIDES A AND B Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2009 | 3 | 0 | 2 |
| 2011 | 2 | 0 | 2 |
| 2016 | 1 | 0 | 1 |
| 2017 | 3 | 0 | 1 |
| 2018 | 3 | 0 | 0 |
| 2019 | 5 | 0 | 1 |
| 2021 | 7 | 1 | 4 |
| 2022 | 4 | 0 | 1 |
| 2023 | 2 | 0 | 1 |
What Is DOCUSATE\SENNOSIDES A AND B Used For?
| Indication | Reports |
|---|---|
| Product used for unknown indication | 128 |
| Constipation | 10 |
DOCUSATE\SENNOSIDES A AND B vs Alternatives: Which Is Safer?
DOCUSATE\SENNOSIDES A AND B vs DOFETILIDE
DOCUSATE\SENNOSIDES A AND B vs DOLUTEGRAVIR
DOCUSATE\SENNOSIDES A AND B vs DOLUTEGRAVIR\LAMIVUDINE
DOCUSATE\SENNOSIDES A AND B vs DOLUTEGRAVIR\LAMIVUDINE\TENOFOVIR DISOPROXIL
DOCUSATE\SENNOSIDES A AND B vs DOLUTEGRAVIR\RILPIVIRINE
DOCUSATE\SENNOSIDES A AND B vs DOMPERIDONE
DOCUSATE\SENNOSIDES A AND B vs DOMPERIDONE\PANTOPRAZOLE
DOCUSATE\SENNOSIDES A AND B vs DONANEMAB-AZBT
DOCUSATE\SENNOSIDES A AND B vs DONEPEZIL
DOCUSATE\SENNOSIDES A AND B vs DONEPEZIL\DONEPEZIL
Official FDA Label for DOCUSATE\SENNOSIDES A AND B
Official prescribing information from the FDA-approved drug label.